Vol 1, No 1 (2017)

Review
Stages of development and implementation of personalized medicine technologies in clinical practice
Sychev D.A.
World Journal of Personalized Medicine. 2017;1(1):1-4
views311
PDF
(Rus)
Pharmacodynamic gene polymorphism and adverse drug reactionsthen applying antipsychotic drugs
Zastrozhin M.S., Sychev D.A., Grishina E.A., Savchenko L.M., Bryun E.A.
World Journal of Personalized Medicine. 2017;1(1):5-12
views177
PDF
(Rus)
The prospect of pluripotent stem cells for diabetes mellitus treatment
Panova A.V., Goliudsova D.V., Kiselev S.L.
World Journal of Personalized Medicine. 2017;1(1):13-17
views358
PDF
(Rus)
Original Studies
Pharmacogenetic evaluation of adverse events’ risk in patients with alcohol withdrawal syndrome taking bromdihydrochlorphenylbenzodiazepine: The role of CYP2C19 gene polymorphisms
Ivashchenko D.V., Ryzhykova K.A., Sozaeva Z.A., Zastrozhin M.S., Grishina E.A., Savchenko L.M., Bryun E.A., Sychev D.A.
World Journal of Personalized Medicine. 2017;1(1):18-26
views184
PDF
(Rus)
Perspectives of pharmacogenetics approach to personalized tamoxifen therapy
Savelyeva M.I., Panchenko J.S., Urvantseva I.A., Ignatova A.K., Poddubnaya I.V.
World Journal of Personalized Medicine. 2017;1(1):27-35
views339
PDF
(Rus)
The personalized approach to neonatal diabetes therapy depending on the genetic defect
Tikhonovich Y.V., Zubkova N.A., Tiulpakov A.N.
World Journal of Personalized Medicine. 2017;1(1):36-39
views345
PDF
(Rus)
Case report
Genotype-based personalized correction of glycemic control in patients with MODY due to mutations in GCK, HNF1A AND HNF4A genes
Zubkova N.A., Gioeva O.A., Tikhonovich Y.V., Petrov V.M., Vasiliev E.V., Tyulpakov A.N., Dedov I.I.
World Journal of Personalized Medicine. 2017;1(1):40-48
views380
PDF
(Rus)